Chang W H, Kortan P, Haber G B
Division of Gastroenterology, The Wellesley Hospital, University of Toronto, Ontario, Canada.
Gastrointest Endosc. 1998 May;47(5):354-62. doi: 10.1016/s0016-5107(98)70218-4.
There is much controversy as to the importance of establishing drainage of both liver lobes in malignant hilar obstruction. The purpose of the present study was to compare survival data in patients with malignant hilar obstruction, stratified according to the Bismuth classification, who had cholangiography with filling of one or both hepatic ducts and subsequently endoscopic or percutaneous drainage of one or both ducts.
A retrospective review was performed for the time period from July 1990 to July 1995, and 224 patients were identified with a presumed diagnosis of a bifurcation tumor. All x-ray films were reviewed and 150 patients finally diagnosed as hilar tumor were classified according to Bismuth type I, II, or III. Type II and III patients were further subclassified with respect to contrast injection into a single or both hepatic duct systems and whether one or both sides were eventually drained.
Data were obtained in 141 patients (4 patients still alive); there were 43 type I, 58 type II, and 40 type III. Type II and III patients were divided into three groups: group A, one lobe opacified with same lobe drained; group B, both lobes opacified with both lobes drained; and group C, both lobes opacified with one lobe drained. Overall median survival for type I, II, and III patients was 160, 131, and 62 days, respectively. Among type II and III patients the median survivals of groups A, B, and C were 145, 225, and 46 days, respectively. Survival was significantly longer in group A vs. group C (p < 0.001), group B vs. group C (p < 0.001, and group A + B (165 days) vs. group C p < 0.001). There was no difference in group A + B versus type I (p=0.90). In addition, when comparing single drain only (group A + C, 80 days) versus double drains (group B, 225 days), there was a significant survival advantage (p < 0.0001).
In bifurcation tumors the best survival was noted in those with bilateral drainage, and the worst survival in those with cholangiographic opacification of both lobes but drainage of only one.
关于在恶性肝门部梗阻中建立双侧肝叶引流的重要性存在诸多争议。本研究的目的是比较根据比氏分类法分层的恶性肝门部梗阻患者的生存数据,这些患者进行了胆管造影,肝管一支或两支显影,随后接受了一支或两支肝管的内镜或经皮引流。
对1990年7月至1995年7月期间进行回顾性研究,确定了224例疑似肝门部肿瘤的患者。复查所有X线片,最终诊断为肝门部肿瘤的150例患者根据比氏I型、II型或III型进行分类。II型和III型患者进一步根据造影剂注入单支或双支肝管系统以及最终一侧或双侧是否进行引流进行亚分类。
获得了141例患者(4例仍存活)的数据;其中I型43例,II型58例,III型40例。II型和III型患者分为三组:A组,一侧肝叶显影且该侧引流;B组,双侧肝叶显影且双侧引流;C组,双侧肝叶显影但仅一侧引流。I型、II型和III型患者的总体中位生存期分别为160天、131天和62天。在II型和III型患者中,A组、B组和C组的中位生存期分别为145天、225天和46天。A组与C组相比生存期显著更长(p<0.001),B组与C组相比(p<0.001),A组+B组(165天)与C组相比p<0.001。A组+B组与I型相比无差异(p=0.90)。此外,比较仅单支引流(A组+C组,80天)与双支引流(B组,225天)时,生存期有显著优势(p<0.0001)。
在肝门部肿瘤中,双侧引流患者的生存期最佳,而双侧肝叶胆管造影显影但仅一侧引流的患者生存期最差。